SCHEMBL9561898

SCHEMBL9561898

O=C1CCc2cc(C(O)CN3CCC(CC4(c5ccccc5)OCCO4)CC3)ccc2N1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 5/20 0.55
GRIN2B Q13224 2/20 0.53
ALDH1A1 P00352 2/20 0.43
ATM Q13315 1/20 0.43
HTR1A P08908 1/20 0.41
DRD2 P14416 1/20 0.41
HTR2A P28223 1/20 0.41
OGT O15294 1/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TBXAS1 P24557 1/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
KDM1A O60341 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL466863 0.81 GRIN2B (0.61) KCNH2GRIN2BALDH1A1ATMHTR1A
SCHEMBL9561851 0.80 GRIN2B (0.56) KCNH2GRIN2BALDH1A1ATMHTR1A
SCHEMBL9562478 0.79 GRIN2B (0.60) KCNH2GRIN2BALDH1A1ATMHTR1A
Hydrochloric Acid SCHEMBL8542941 0.78 MEN1 (0.56) KCNH2GRIN2BALDH1A1ATMOGT
SCHEMBL9562306 0.77 KCNH2 (0.57) KCNH2GRIN2BALDH1A1ATMHTR1A
SCHEMBL8439768 0.77 KCNH2 (0.54) KCNH2GRIN2BALDH1A1ATMHTR1A
SCHEMBL8301971 0.76 KCNH2 (0.52) KCNH2GRIN2BALDH1A1ATMHTR1A
SCHEMBL8549343 0.74 GRIN2B (0.59) GRIN2BOGTMEN1KMT2A
SCHEMBL5467351 0.74 KCNH2 (0.55) KCNH2GRIN2BALDH1A1ATMHTR1A
SCHEMBL9562529 0.74 KCNH2 (0.57) KCNH2GRIN2BHTR2ABCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0524846-A1 2-(Piperidin-1-yl)ethanol derivatives, their preparation and their use in therapeutics SYNTHELABO (FR) 1993-01-27 EP disclosed